Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him.
Fourteen-year company veteran Richard Lapthorne will step down as Amersham chairman of the board May 7. Donald Brydon, who has been a nonexecutive director of Amersham for six years and is chair of the company's audit committee, will succeed him. Lapthorne joined the Amersham board as a nonexecutive director in 1988. He served four years as chairman.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.